MedPath

JI XING PHARMACEUTICALS AUSTRALIA PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

JX09 SAD/MAD in Healthy Participants

Phase 1
Recruiting
Conditions
Resistant Hypertension
Interventions
Drug: JX09 or placebo MAD
Drug: JX09 or placebo SAD
First Posted Date
2023-12-27
Last Posted Date
2024-02-26
Lead Sponsor
Ji Xing Pharmaceuticals Australia Pty Ltd
Target Recruit Count
92
Registration Number
NCT06183671
Locations
🇦🇺

Nucleus Network Pty Ltd, Melbourne, Australia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.